| Titolo |
Pubblicato in |
Anno |
| Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection. Prospective cohort study |
ECLINICALMEDICINE |
2024 |
| In-label, off-label prescription, efficacy and tolerability of dalbavancin. Report from a National Registry |
INFECTION |
2024 |
| The long-term Immunogenicity of mRNABNT162b third vaccine dose in solid organ transplant recipients |
VACCINES |
2024 |
| Steroid use in measles: A retrospective cohort study during the 2017 outbreak in tertiary referral center, Rome and Latina, Italy |
JOURNAL OF INFECTION AND CHEMOTHERAPY |
2024 |
| Neutrophil Cathepsin G and Thrombosis in COVID-19 |
CIRCULATION RESEARCH |
2024 |
| Dysregulated inflammatory cytokine levels may be useful markers in a better up-dated management of COVID 19 |
CURRENT ISSUES IN MOLECULAR BIOLOGY |
2024 |
| Association Between NOX2-Mediated Oxidative Stress, Low-Grade Endotoxemia, Hypoalbuminemia, and Clotting Activation in COVID-19 |
ANTIOXIDANTS |
2024 |
| Memory T Cells Subpopulations in a Cohort of COVID-19 Vaccinated or Recovered Subjects |
VIRAL IMMUNOLOGY |
2024 |
| Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route |
VACCINES |
2024 |
| Association between PaO2/FiO2 ratio and thrombotic events in COVID-19 patients |
INTERNAL AND EMERGENCY MEDICINE |
2023 |
| Systemic, mucosal immune activation and psycho-sexual health in art-suppressed women living with HIV. Evaluating biomarkers and environmental stimuli |
VIRUSES |
2023 |
| Use of remdesivir in patients with SARS-CoV-2 Pneumonia in a real-life setting during the second and third COVID-19 epidemic waves |
VIRUSES |
2023 |
| Evaluation of baff, april and cd40l in ocrelizumab-treated pwms and infectious risk |
BIOLOGY |
2023 |
| Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use |
VIRUSES |
2023 |
| Unexpected rise in the circulation of complex hbv variants enriched of hbsag vaccine-escape mutationshbvn HB genotype-d. Potential impact on hbsag detection/quantification and vaccination strategies |
EMERGING MICROBES & INFECTIONS |
2023 |
| Tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) and pulmonary involvement in COVID-19 pneumonia |
BIOMOLECULES |
2023 |
| GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial |
CELL REPORTS MEDICINE |
2023 |
| Biomarkers of neurological damag. From acute stage to post-acute sequelae of covid-19 |
CELLS |
2023 |
| Immunogenicity and efficacy of vaccination in people living with human immunodeficiency virus |
VIRUSES |
2023 |
| Prevalence of hepatitis d virus infection in central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication |
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES |
2023 |
